Stay updated on SB414 PK, PD, Safety in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the SB414 PK, PD, Safety in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SB414 PK, PD, Safety in Psoriasis Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the SB414 psoriasis study is displayed, with its study design, participant criteria, locations, treatments, and outcome measures.
    Difference
    42%
    Check dated 2026-11-07T12:29:41.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:21:32.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    An NIH-wide banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T12:58:11.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:13:58.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The revision identifier in the page footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T13:51:11.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study content, replacing the study details with an access-denied message. This prevents viewing the trial information and related navigation on the ClinicalTrials.gov record.
    Difference
    17%
    Check dated 2026-09-19T18:53:14.000Z thumbnail image

Stay in the know with updates to SB414 PK, PD, Safety in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SB414 PK, PD, Safety in Psoriasis Clinical Trial page.